1Life Healthcare (One Medical) Announces Date of its First Quarter 2022 Results Conference Call
SAN FRANCISCO, April 27, 2022 (GLOBE NEWSWIRE) -- 1Life Healthcare, Inc. (One Medical) (Nasdaq: ONEM) today announced that its first...
Day: April 27, 2022
Allied Corp Announces Initial US$147,000 Purchase Order Continuing into Monthly Supply Agreement for Brazilian Specialty Cancer Care Hospital
KELOWNA, British Columbia, April 27, 2022 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to...
Vir Biotechnology Announces New Data From the MARCH Hepatitis B Trial, Unveils New Hepatitis D Clinical Program and Highlights Broad Hepatitis Portfolio at Virtual Hepatitis Portfolio R&D Day
– Strategic clinical program for hepatitis B and D with potential for multiple value drivers in 2022 – – Virtual R&D...
Panbela to Host Virtual R&D Day
MINNEAPOLIS, April 27, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics...
T2 Biosystems Announces Submission for FDA Breakthrough Device Designation for T2Biothreat Panel
LEXINGTON, Mass., April 27, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens...
WIMI Hologram Academy: The application of virtual reality technology in balance function disorder after cerebral apoplexy
HONG KONG, April 27, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center,...
Sarepta Therapeutics to Announce First Quarter 2022 Financial Results and Recent Corporate Developments on May 4, 2022
CAMBRIDGE, Mass., April 27, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare...
BioCorRx Begins Recruitment for Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
ANAHEIM, CA, April 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of...
SCYNEXIS Presents Data Analyses Showing Ibrexafungerp’s Potential to Fight Invasive Candidiasis and Candidemia, Including Infections Caused by Candida Auris, During the 32nd Annual European Congress of Clinical Microbiology & Infectious Diseases
New interim analysis of the Phase 3 CARES study showed complete or partial response in 78% of the 18 patients...
Allogene Therapeutics to Report First Quarter 2022 Financial Results on May 4, 2022
Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ETSOUTH SAN FRANCISCO, Calif., April 27, 2022 (GLOBE NEWSWIRE) --...
Praxis Precision Medicines Showcases Largest Targeted Epilepsy Portfolio in Industry at 2022 Epilepsy Day
Live event in New York City and webcast to start at 8:30 a.m. ETBOSTON, April 27, 2022 (GLOBE NEWSWIRE) --...
Novo Nordisk A/S – Articles of Association
Novo Nordisk's Articles of Association 2022 after capital reduction, 27 April 2022 Attachment NN_Articles_of_Association_2022_After CapReduction
Novo Nordisk A/S – Reduction of the share capital
Bagsværd, Denmark, 27 April 2022 – At Novo Nordisk’s Annual General Meeting on 24 March 2022, it was decided to...
Codex DNA Unveils Automated Synthetic Biology Solutions for Antibody and Protein Engineering of Biotherapeutic Targets at 18th Annual PEGS Boston Conference and Expo
BioXp™ system and RapidAMP™ cell-free DNA kit allow scientists to synthesize, clone, and amplify antibody-variable regions based on a digital...
iCAD to Report First Quarter 2022 Financial Results on Wednesday, May 11
NASHUA, N.H., April 27, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection...
AcelRx Hosting Key Opinion Leader Webinar on Niyad™ Nafamostat Program
Key Opinion Leaders participating will be Stuart Goldstein, MD, Cincinnati Children’s Hospital and Lakhmir Chawla, MD, former Chief of the Division...
Volta Medical VX1 AI Software to be Featured at Heart Rhythm 2022
- Company’s VX1 AI software for use in atrial fibrillation will be featured during several events at the Congress -...
Comprehensive Analysis in Frontiers in Neuroscience Highlights Acumen Pharmaceuticals’ New Approach to Treating Alzheimer’s Disease
Acumen focused on developing investigational monoclonal antibody targeting amyloid beta oligomersCHARLOTTESVILLE, Va. and CARMEL, Ind., April 27, 2022 (GLOBE NEWSWIRE)...
Allogene Therapeutics Receives FDA Orphan-Drug Designation for ALLO-605, its First TurboCAR™ T Cell Product Candidate, for the Treatment of Multiple Myeloma
ODD Follows FDA Fast Track Designation Granted for ALLO-605 in Q2 2021ALLO-605 is in Phase 1 in the IGNITE Trial...
Shockwave Medical Announces Details for Conference Call Discussing First Quarter 2022 Results and Participation in Upcoming Investor Conferences
SANTA CLARA, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of...
